Reported 5 months ago
Cassava Sciences has appointed Richard Barry as Executive Chairman and principal executive officer following the resignation of CEO Remi Barbier. The company is now in search of a permanent CEO while focusing on maintaining transparency and scientific rigor in its ongoing Alzheimer's trials. This includes adhering to strict FDA protocols and ensuring open communication with stakeholders.
Source: YAHOO